173 related articles for article (PubMed ID: 25516793)
1. Crystal Structure of Sphingosine Kinase 1 with PF-543.
Wang J; Knapp S; Pyne NJ; Pyne S; Elkins JM
ACS Med Chem Lett; 2014 Dec; 5(12):1329-33. PubMed ID: 25516793
[TBL] [Abstract][Full Text] [Related]
2. Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors.
Li H; Sibley CD; Kharel Y; Huang T; Brown AM; Wonilowicz LG; Bevan DR; Lynch KR; Santos WL
Bioorg Med Chem; 2021 Jan; 30():115941. PubMed ID: 33385956
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
Lynch KR; Thorpe SB; Santos WL
Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits.
Schnute ME; McReynolds MD; Carroll J; Chrencik J; Highkin MK; Iyanar K; Jerome G; Rains JW; Saabye M; Scholten JA; Yates M; Nagiec MM
J Med Chem; 2017 Mar; 60(6):2562-2572. PubMed ID: 28231433
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.
Congdon MD; Childress ES; Patwardhan NN; Gumkowski J; Morris EA; Kharel Y; Lynch KR; Santos WL
Bioorg Med Chem Lett; 2015 Nov; 25(21):4956-4960. PubMed ID: 25862200
[TBL] [Abstract][Full Text] [Related]
7. Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression.
Yuza K; Nakajima M; Nagahashi M; Tsuchida J; Hirose Y; Miura K; Tajima Y; Abe M; Sakimura K; Takabe K; Wakai T
J Surg Res; 2018 Dec; 232():186-194. PubMed ID: 30463717
[TBL] [Abstract][Full Text] [Related]
8. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
[TBL] [Abstract][Full Text] [Related]
9. Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles.
Houck JD; Dawson TK; Kennedy AJ; Kharel Y; Naimon ND; Field SD; Lynch KR; Macdonald TL
ACS Med Chem Lett; 2016 May; 7(5):487-92. PubMed ID: 27190598
[TBL] [Abstract][Full Text] [Related]
10. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.
Tanfin Z; Serrano-Sanchez M; Leiber D
Cell Signal; 2011 Dec; 23(12):1997-2004. PubMed ID: 21803151
[TBL] [Abstract][Full Text] [Related]
11. Mobilization studies in mice deficient in sphingosine kinase 2 support a crucial role of the plasma level of sphingosine-1-phosphate in the egress of hematopoietic stem progenitor cells.
Adamiak M; Chelvarajan L; Lynch KR; Santos WL; Abdel-Latif A; Ratajczak MZ
Oncotarget; 2017 Sep; 8(39):65588-65600. PubMed ID: 29029455
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine kinase 1/sphingosine-1-phosphate regulates the expression of interleukin-17A in activated microglia in cerebral ischemia/reperfusion.
Lv M; Zhang D; Dai D; Zhang W; Zhang L
Inflamm Res; 2016 Jul; 65(7):551-62. PubMed ID: 27002656
[TBL] [Abstract][Full Text] [Related]
13. Building a better sphingosine kinase-1 inhibitor.
Lynch KR
Biochem J; 2012 May; 444(1):e1-2. PubMed ID: 22533672
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of sphingosine kinase 1 substrate recognition and catalysis.
Wang Z; Min X; Xiao SH; Johnstone S; Romanow W; Meininger D; Xu H; Liu J; Dai J; An S; Thibault S; Walker N
Structure; 2013 May; 21(5):798-809. PubMed ID: 23602659
[TBL] [Abstract][Full Text] [Related]
15. Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1.
Fukuda Y; Kihara A; Igarashi Y
Biochem Biophys Res Commun; 2003 Sep; 309(1):155-60. PubMed ID: 12943676
[TBL] [Abstract][Full Text] [Related]
16. Regulation and function of sphingosine kinase 2 in diseases.
Song DD; Zhou JH; Sheng R
Histol Histopathol; 2018 May; 33(5):433-445. PubMed ID: 29057430
[TBL] [Abstract][Full Text] [Related]
17. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
[TBL] [Abstract][Full Text] [Related]
18. Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer's disease brain.
Dominguez G; Maddelein ML; Pucelle M; Nicaise Y; Maurage CA; Duyckaerts C; Cuvillier O; Delisle MB
Acta Neuropathol Commun; 2018 Apr; 6(1):25. PubMed ID: 29615132
[TBL] [Abstract][Full Text] [Related]
19. Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments.
Magli E; Corvino A; Fiorino F; Frecentese F; Perissutti E; Saccone I; Santagada V; Caliendo G; Severino B
Curr Pharm Des; 2019; 25(9):956-968. PubMed ID: 30947653
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine kinase 1/sphingosine-1-phosphate (S1P)/S1P receptor axis is involved in ovarian cancer angiogenesis.
Dai L; Liu Y; Xie L; Wu X; Qiu L; Di W
Oncotarget; 2017 Sep; 8(43):74947-74961. PubMed ID: 29088837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
